Search hospitals > California > Santa Barbara
Sansum Clinic
Claim this profileSanta Barbara, California 93105
Global Leader in Breast Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
65 reported clinical trials
3 medical researchers
Summary
Sansum Clinic is a medical facility located in Santa Barbara, California. This center is recognized for care of Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Cancer, Ovarian Cancer and other specialties. Sansum Clinic is involved with conducting 65 clinical trials across 76 conditions. There are 3 research doctors associated with this hospital, such as Mukul Gupta, MD, Ryan Kendle, MD, and Gregg Newman, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 negative
Top PIs
Mukul Gupta, MDSansum Clinic2 years of reported clinical research
Studies Breast Cancer
Studies Adenocarcinoma
6 reported clinical trials
15 drugs studied
Ryan Kendle, MDSansum Clinic3 years of reported clinical research
Studies Ovarian Cancer
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
4 drugs studied
Gregg Newman, MDSansum Clinic SC3 years of reported clinical research
Studies Prostate Cancer
Studies Ovarian Cancer
2 reported clinical trials
6 drugs studied
Clinical Trials running at Sansum Clinic
Breast Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Tumors
PD-L1 Negative
Digestive System Tumors
Gastrointestinal Tumors
Gastric Neoplasm
Stomach Cancer
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sansum Clinic?
Sansum Clinic is a medical facility located in Santa Barbara, California. This center is recognized for care of Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Cancer, Ovarian Cancer and other specialties. Sansum Clinic is involved with conducting 65 clinical trials across 76 conditions. There are 3 research doctors associated with this hospital, such as Mukul Gupta, MD, Ryan Kendle, MD, and Gregg Newman, MD.